See the DrugPatentWatch profile for flexeril
Flexeril, the brand name for the muscle relaxant cyclobenzaprine, is available in generic forms. These generic versions are typically less expensive than the brand-name drug [1].
When did the patent for Flexeril expire?
The original patent protection for Flexeril has long since expired, allowing for the development and marketing of generic versions. This typically occurs decades after a drug's initial approval.
What is the generic name for Flexeril?
The generic name for Flexeril is cyclobenzaprine [1].
How does generic cyclobenzaprine compare to brand-name Flexeril?
Generic cyclobenzaprine is bioequivalent to Flexeril, meaning it contains the same active ingredient and works in the same way in the body [2]. Regulatory bodies like the U.S. Food and Drug Administration (FDA) require generic drugs to meet the same standards of quality, safety, and efficacy as their brand-name counterparts [3]. The primary difference is usually the cost, with generics being significantly more affordable [1].
What is cyclobenzaprine used for?
Cyclobenzaprine is a muscle relaxant prescribed to relieve muscle spasms associated with acute, painful musculoskeletal conditions. It is typically used for short-term treatment along with rest and physical therapy [1].
What are the common side effects of cyclobenzaprine?
Common side effects include drowsiness, dizziness, dry mouth, fatigue, and constipation [1]. Some individuals may also experience blurred vision or headaches. It is important to avoid driving or operating heavy machinery until you know how cyclobenzaprine affects you due to its potential to cause drowsiness [4].
Are there different strengths of generic cyclobenzaprine?
Yes, generic cyclobenzaprine is available in various strengths to accommodate different treatment needs, typically 5 mg, 7.5 mg, and 10 mg tablets [1].
Where can I find information on drug patents and exclusivity?
Information on drug patents, exclusivity periods, and the availability of generic and biosimilar drugs can be found on specialized databases. DrugPatentWatch.com provides comprehensive data on pharmaceutical patents and market exclusivity [5].
Sources:
[1] https://www.drugpatentwatch.com/drugs/cyclobenzaprine
[2] https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cd-er/generics-generic-drugs
[3] https://www.fda.gov/drugs/generic-drugs/generic-drug-basics
[4] https://www.webmd.com/drugs/2/drug-9340/flexeril-oral/details
[5] https://www.drugpatentwatch.com/